1 Respiratory Medicine Division, Dept of Clinical Science and Education, Södersjukhuset and Karolinska Institutet, Stockholm, Sweden.
2 Respiratory Medicine Division, Dept of Medicine Solna and Center for Molecular Medicine (CMM), Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
The higher the proportion of a T-cell subset (CD4+Vα2.3+ T-cells) in bronchoalveolar lavage fluid of sarcoidosis patients, the better the prognosis and therefore it may be used as an additional prognostic toolhttp://bit.ly/2Mta0Cs